D
Sonoma Pharmaceuticals, Inc. SNOA
$5.09 $0.030.59% NASDAQ
Recommendation
Prev Close
$5.23
Volume
157,674
Avg Vol (90D)
1,682,366
Market Cap
$8.59M
Dividend & Yield
--
52-Week Range
$1.75 - $6.92
P/E (TTM)
--
EPS (TTM)
-$2.46
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock
8/19/2025 - Zacks Investment Research
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above 200-Day Moving Average - What's Next?
8/16/2025 - Ticker Report
Why Is Sonoma Pharmaceuticals Stock (SNOA) Up 105% Today?
8/15/2025 - TipRanks Financial Blog
Sonoma Pharmaceuticals Soars 95% After Walmart, Amazon Retail Debut
8/14/2025 - GuruFocus
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
8/14/2025 - GuruFocus
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. ...
8/13/2025 - GuruFocus
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. Chains
8/13/2025 - ACCESS Newswire
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results
8/8/2025 - GuruFocus
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results SNOA Stock News
8/7/2025 - GuruFocus
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial Results
8/7/2025 - ACCESS Newswire
Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Price Crosses Above 200-Day Moving Average - Here's Why
7/15/2025 - Ticker Report
Sonoma Pharmaceuticals (SNOA) Is Attractively Priced Despite Fast-paced Momentum
7/14/2025 - Zacks Investment Research
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results
6/18/2025 - GuruFocus
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results SNOA ...
6/17/2025 - GuruFocus
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results
6/17/2025 - Accesswire
A Piece Of The Puzzle Missing From Sonoma Pharmaceuticals, Inc.'s (NASDAQ:SNOA) 35% Share Price Climb
4/26/2025 - Simply Wall St
Sonoma Pharmaceuticals (SNOA) Expands Acne Product Line to UK Retailers
4/23/2025 - GuruFocus
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch ...
4/23/2025 - GuruFocus
Sonoma Pharmaceuticals (SNOA) Expands Reach with UK Product Registration SNOA Stock News
4/22/2025 - GuruFocus
Sonoma Pharmaceuticals registers acne products in the United Kingdom
4/22/2025 - The Fly
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain
4/22/2025 - Accesswire
Short Interest in Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Drops By 72.3%
4/16/2025 - Ticker Report
Financial Review: Sonoma Pharmaceuticals (NASDAQ:SNOA) vs. Inspira Technologies Oxy B.H.N. (NASDAQ:IINN)
4/14/2025 - Ticker Report
Fast-paced Momentum Stock Sonoma Pharmaceuticals (SNOA) Is Still Trading at a Bargain
3/27/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$14.91M
EBITDA (TTM)
-$3.50M
EBIT (TTM)
-$3.63M
Net Income (TTM)
-$3.56M
Balance Sheet
Total Assets (Q)
$14.59M
Total Debt (Q)
$675.00K
Total Liabilities (Q)
$10.54M
Book Value Per Share (Q)
$2.47
Cash Flow
Cash from Operations (TTM)
-$1.19M
Cash from Investing (TTM)
-$181.00K
Cash from Financing (TTM)
$2.34M
Net Change in Cash (TTM)
$1.02M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
1.31
7-Day Total Return
69.67%
30-Day Total Return
29.19%
60-Day Total Return
60.06%
90-Day Total Return
122.27%
Year to Date Total Return
89.93%
1-Year Total Return
14.59%
2-Year Total Return
-70.06%
3-Year Total Return
-91.74%
5-Year Total Return
-96.93%
52-week Low
Apr 07, 2025 - $1.75
52-week High
Aug 14, 2025 - $6.92
Valuation
Market Cap
$8.59M - Nano Cap
Enterprise Value
$5.66M
Price/Sales (TTM)
0.58
Price/Book (Q)
2.12
Dividends and Shares
Shares Outstanding
1.64
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
sonomapharma.com
Phone Number
800 759 9305
Address
5445 Conestoga Court
Boulder, CO 80301
Country
United States
Year Founded
1999
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological... more
NASDAQ 08/22/2025 4:00PM Eastern Quotes delayed